98 related articles for article (PubMed ID: 6682284)
21. Extended safety and efficacy data on S-1 plus cisplatin in patients with untreated, advanced gastric carcinoma in a multicenter phase II study.
Lenz HJ; Lee FC; Haller DG; Singh D; Benson AB; Strumberg D; Yanagihara R; Yao JC; Phan AT; Ajani JA
Cancer; 2007 Jan; 109(1):33-40. PubMed ID: 17133415
[TBL] [Abstract][Full Text] [Related]
22. A multi-center, late phase II clinical trial of Genexol (paclitaxel) and cisplatin for patients with advanced gastric cancer.
Park SR; Oh DY; Kim DW; Kim TY; Heo DS; Bang YJ; Kim NK; Kang WK; Kim HT; Im SA; Suh JH; Kim HK; Kim HK
Oncol Rep; 2004 Nov; 12(5):1059-64. PubMed ID: 15492793
[TBL] [Abstract][Full Text] [Related]
23. Phase 2 evaluation of topotecan administered on a 3-day schedule in the treatment of platinum- and paclitaxel-refractory ovarian cancer.
Markman M; Kennedy A; Webster K; Kulp B; Peterson G; Belinson J
Gynecol Oncol; 2000 Oct; 79(1):116-9. PubMed ID: 11006042
[TBL] [Abstract][Full Text] [Related]
24. Oral etoposide (VP16) in platinum-resistant epithelial ovarian cancer (EOC).
Alici S; Saip P; Eralp Y; Aydiner A; Topuz E
Am J Clin Oncol; 2003 Aug; 26(4):358-62. PubMed ID: 12902885
[TBL] [Abstract][Full Text] [Related]
25. Combination chemotherapy comprising 5-fluorouracil, leucovorin, etoposide, and cis-diamminedichloroplatinum for the treatment of advanced gastric cancer.
Mochizuki F; Fujii M; Kasakura Y; Yamagata M; Kochi M; Wakabayashi K; Kanamori N; Takayama T
J Cancer Res Clin Oncol; 2002 Sep; 128(9):493-6. PubMed ID: 12242513
[TBL] [Abstract][Full Text] [Related]
26. A pilot study of combination chemotherapy with S-1 and low-dose cisplatin for highly advanced gastric cancer.
Takahashi T; Saikawa Y; Yoshida M; Kitagawa Y; Otani Y; Kubota T; Kumai K; Kitajima M
Anticancer Res; 2006; 26(2B):1631-5. PubMed ID: 16619584
[TBL] [Abstract][Full Text] [Related]
27. Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer.
Beckmann GK; Hoppe F; Pfreundner L; Flentje MP
Head Neck; 2005 Jan; 27(1):36-43. PubMed ID: 15459918
[TBL] [Abstract][Full Text] [Related]
28. Phase II trial of cisplatin in advanced gastric cancer.
Vogl SE; Camacho FJ; Engstrom PF; Bennett JM
Cancer Treat Rep; 1984 Dec; 68(12):1497-8. PubMed ID: 6542449
[No Abstract] [Full Text] [Related]
29. [Clinical phase II study of TK-117 by Cooperative Study Group. Effects on gastric cancer].
Suzuki H
Gan To Kagaku Ryoho; 1985 May; 12(5):1119-24. PubMed ID: 3158282
[TBL] [Abstract][Full Text] [Related]
30. Cisplatin in patients with gastric cancer: a Cancer and Leukemia Group B phase II study.
Perry MC; Green MR; Mick R; Schein P
Cancer Treat Rep; 1986 Mar; 70(3):415-6. PubMed ID: 3955555
[No Abstract] [Full Text] [Related]
31. Phase II study of cis-dichlorodiammineplatinum(II) (NSC-119875) in combination with cyclophosphamide (NSC-26271) in the treatment of human malignancies.
Piel IJ; Perlia CP
Cancer Chemother Rep; 1975; 59(5):995-9. PubMed ID: 1106849
[TBL] [Abstract][Full Text] [Related]
32. [Evaluation of the therapeutic and toxic action of platinum cis-dichlorodiamine].
Fiserová J; Dostálová O; Drobnik J; Faistavr J; Holik F
Vopr Onkol; 1977; 23(8):68-74. PubMed ID: 333750
[TBL] [Abstract][Full Text] [Related]
33. Clinical trial of combined therapy with adriamycin and cis-dichlorodiammineplatinum(II).
Mills RC; Maurer LH; Forcier RJ; Grace WR; Burke GP; Karp DD; Smith RC; Mcintyre OR; Bean C
Cancer Treat Rep; 1977; 61(3):477-9. PubMed ID: 872146
[No Abstract] [Full Text] [Related]
34. cis-Dichlorodiamminepltinum(II) in adult patients: Southwest Oncology Group Studies.
Stephens R; Coltman C; Rossof A; Samson M; Panettiere F; Al-Sarraf M; Alberts D; Bonnet J
Cancer Treat Rep; 1979; 63(9-10):1609-10. PubMed ID: 498160
[TBL] [Abstract][Full Text] [Related]
35. [Cancer chemotherapy on gastric cancer (author's transl)].
Kurihara M; Shirakabe H; Izumi T; Miyasaka K; Maruyama T; Yamaya F; Yarita T; Yamamoto I; Ariyama J; Wakabayashi Y; Kamano T; Yasui A; Karasawa Y; Onuma H
Nihon Gan Chiryo Gakkai Shi; 1978 Dec; 13(6):700-11. PubMed ID: 744887
[No Abstract] [Full Text] [Related]
36. [Mitomycin C and cisplatin as single agents in the second-line treatment of advanced gastric cancer].
Di Lauro L; Balice A; Carpano S; Papaldo P; Lopez M
Clin Ter; 1985 Dec; 115(5):361-4. PubMed ID: 3938357
[No Abstract] [Full Text] [Related]
37. [Trials on expanding the clinical application of cisplatin].
Ogawa M
Gan To Kagaku Ryoho; 1987 Apr; 14(4):1004-10. PubMed ID: 3551845
[TBL] [Abstract][Full Text] [Related]
38. Treatment of genitourinary tumours with cis-dichlorodiammineplatinum(II): experience in 250 patients.
Merrin CE
Cancer Treat Rep; 1979; 63(9-10):1579-84. PubMed ID: 574057
[No Abstract] [Full Text] [Related]
39. Phase II study of cis-dischlorodiammineplatinum(II) in stage IVB Hodgkin's disease.
Corder MP; Elliott TE; Maguire LC; Leimert JT; Panther SK; Lachenbruch PA
Cancer Treat Rep; 1979 May; 63(5):763-6. PubMed ID: 455312
[TBL] [Abstract][Full Text] [Related]
40. Phase II study of cis-dichlorodiammineplatinum(II) in childhood osteosarcoma: Children's Cancer Study Group Report.
Baum ES; Gaynon P; Greenberg L; Krivit W; Hammond D
Cancer Treat Rep; 1979; 63(9-10):1621-7. PubMed ID: 291484
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
